BioCardia, Inc. Common Stock

Go to BioCardia, Inc. Common Stock Website

$1.96

0.00 (0.00%)
Live
Previous Close

$1.96

Day Range

$0 - $0

Previous Day Range

$1.73 - $1.96

Market Cap

$11.8 million USD

Day Vol.

0

Previous Day Vol.

11.3 million

Currency

USD

Primary Exchange

Nasdaq

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP aut...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

The FDA has approved a protocol amendment for BioCardia's CardiAMP Heart Failure II Trial, allowing more patients to receive the autologous cell therapy. The amendment incorporates a personalized treatment plan based on a pre-procedural cell population analysis, expected to enhance the clinical experience and market opportunity.

Related tickers: BCDA.

Read Full Article

BioCardia announces that the USPTO has granted Patent No: 11,986,611 titled “Radial and Transendocardial Delivery Catheter,” with a 2036 expiration date.

Related tickers: BCDA.

Read Full Article
Trending Tickers

Please sign in to view